Best Practices for Aripiprazole Lauroxil Administration: From Formulation Development to Injection Technique

Area of Science:

• Pharmacology and Pharmaceutical Technology
• Neuroscience and Psychiatry

Background:

• Long-acting injectable (LAI) antipsychotics are crucial for schizophrenia management.
• Varied formulation technologies exist for LAIs, influencing dosing and administration.
• Clinical reviews often overlook formulation's impact on injection safety and technique.

Purpose of the Study:

• To review the link between LAI formulation technology and clinical injection practices.
• To focus on aripiprazole lauroxil's formulation and its clinical implications for schizophrenia treatment.

Main Methods:

• Review of formulation development for long-acting injectable antipsychotics.
• Focus on aripiprazole lauroxil's aqueous-based suspension formulation.
• Analysis of the relationship between formulation properties and recommended injection techniques.

Main Results:

• Aripiprazole lauroxil utilizes an aqueous suspension in a prefilled syringe for sustained plasma release.
• Specific injection techniques are critical for this formulation's proper function.
• Tapping/shaking to resuspend particles and rapid injection are key for optimal delivery.

Conclusions:

• Formulation technology is clinically relevant for LAI antipsychotics, affecting injection safety and efficacy.
• Understanding aripiprazole lauroxil's formulation guides essential injection practices.
• Proper technique ensures optimal therapeutic outcomes for patients with schizophrenia receiving aripiprazole lauroxil.